Join a StartupCareer GrowthStudent ProgramsStartup AcceleratorsAngel InvestingVenture CapitalReviews
Loyal
Loyal Logo

Loyal

A clinical-stage veterinary medicine company on a mission to help dogs live longer, healthier lives.

About

Founded

2019

Headquarters

San Francisco, California

Industry

Biotech, Pets

Company Description

Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too. By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species. At Loyal, our first products to market are focused on longevity and healthspan in dogs.

Quick Links

WebsiteJobs

Funding

Total Raised

$125 million

Valuation

Undisclosed

Significant Investors

Khosla Ventures, First Round Capital, The Longevity Fund, Lachy Groom, BoxGroup, Collab Fund, Bain Capital Ventures, Valor Equity Partners

Company Traction

  • Loyal’s team has published 152 papers, worked on 56 clinical drug programs, and combined for 192 years of research.
  • Loyal received protocol concurrence from the FDA for its companion dog longevity study.

Leadership Team

  • Celine Halioua: Founder of Loyal. Former Chief of Staff at The Longevity Fund.
  • Stacy Ross: VP, CMC at Loyal. Former Director, CMC Project Lead at Sage Therapeutics.
  • Karen Greenwood: SVP, Regulatory, and Strategy at Loyal. Former VP of Product Management at Kindred Biosciences.
  • John Poisson: Chief Creative Officer at Loyal. Former Founder & CEO of Wantful.

Press

People also viewed